Nifty

:

25285.35

Sensex

:

82500.82

103.55 (0.41%)
328.72 (0.40%)

Login

Nifty
Sensex

:
:

25285.35
82500.82

103.55 (0.41%)
328.72 (0.40%)

Vivimed Labs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 532660 | NSE: VIVIMEDLAB

Watchlist

NSE BSE

Not traded in the last 30 days

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

40.63
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

392.32
N/A
28.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-21.72
-
-14.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-41.32

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-54.01

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

0.47
0.58
1.89

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-19.41
-54.16
-30.85

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 17.94 24.64 -27.19% 22.57 36.39 -37.98% 34.23 37.14 -7.84% 22.16 30.28 -26.82%
Expenses 18.48 35.71 -48.25% 25.06 65.21 -61.57% 34.41 36.25 -5.08% 22.95 35.69 -35.70%
EBITDA -0.54 -11.07 - -2.48 -28.82 - -0.18 0.88 - -0.79 -5.41 -
EBIDTM -3.00% -44.95% -10.99% -79.22% -0.52% 2.38% -3.55% -17.86%
Other Income 0.36 0.00 0 4.15 7.37 -43.69% 0.00 0.04 -100.00% 0.03 2.16 -98.61%
Interest 0.52 0.25 108.00% 1.48 -33.69 - 0.43 13.16 -96.73% 0.37 11.82 -96.87%
Depreciation 4.80 3.79 26.65% 4.61 4.96 -7.06% 6.37 4.49 41.87% 3.86 4.49 -14.03%
PBT -5.50 -15.11 - -4.42 7.28 - -6.97 -16.72 - -5.00 -19.56 -
Tax 0.00 0.00 0 0.00 1.77 -100.00% 0.00 -0.55 - 0.00 0.00 0
PAT -5.50 -15.11 - -4.42 5.51 - -6.97 -16.17 - -5.00 -19.56 -
PATM -30.63% -61.34% -19.57% 15.15% -20.37% -43.54% -22.54% -64.60%
EPS -0.66 -1.82 - -0.53 0.67 - -0.84 -1.95 - -0.60 -2.36 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 21.39 29.37 -27.17% 25.61 38.62 -33.69% 36.51 41.46 -11.94% 24.77 33.64 -26.37%
Expenses 21.67 40.37 -46.32% 28.08 67.09 -58.15% 35.45 40.19 -11.79% 25.41 39.54 -35.74%
EBITDA -0.28 -11.00 - -2.46 -28.47 - 1.06 1.27 -16.54% -0.64 -5.90 -
EBIDTM -1.32% -37.45% -9.62% -73.73% 2.89% 3.07% -2.59% -17.54%
Other Income 0.38 0.06 533.33% 4.22 7.63 -44.69% 0.07 0.04 75.00% 0.03 2.20 -98.64%
Interest 0.58 0.30 93.33% 1.74 -33.33 - 0.48 13.21 -96.37% 0.43 11.89 -96.38%
Depreciation 5.01 4.01 24.94% 5.50 5.83 -5.66% 6.62 4.70 40.85% 4.10 4.70 -12.77%
PBT -5.49 -15.24 - -5.49 6.65 - -5.97 -16.60 - -5.14 -20.30 -
Tax 0.00 0.00 0 0.11 1.39 -92.09% 0.00 -0.55 - 0.00 0.00 0
PAT -5.49 -15.24 - -5.60 5.26 - -5.97 -16.05 - -5.14 -20.30 -
PATM -25.68% -51.90% -21.86% 13.63% -16.37% -38.71% -20.75% -60.34%
EPS -0.66 -1.84 - -0.68 0.63 - -0.72 -1.94 - -0.62 -2.45 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 96.90 103.60 136.80 176.82 218.37 276.61 251.81 261.39 569.84 319.39 430.15 Net Sales Growth -24.56% -24.27% -22.63% -19.03% -21.05% 9.85% -3.67% -54.13% 78.42% -25.75% Cost Of Goods Sold 52.97 58.33 67.32 268.64 143.41 150.30 80.30 86.40 179.93 131.55 197.90 Gross Profit 43.93 45.27 69.48 -91.81 74.96 126.31 171.51 174.99 389.91 187.85 232.24 GP Margin 45.33% 43.70% 50.79% -51.92% 34.33% 45.66% 68.11% 66.95% 68.42% 58.82% 53.99% Total Expenditure 100.90 118.12 169.93 364.73 227.40 243.87 184.32 183.05 319.35 232.56 320.10 Power & Fuel Cost - 3.48 4.87 8.72 7.55 8.99 8.92 10.83 15.13 11.03 15.81 % Of Sales - 3.36% 3.56% 4.93% 3.46% 3.25% 3.54% 4.14% 2.66% 3.45% 3.68% Employee Cost - 23.04 29.45 29.67 31.68 31.87 37.88 34.09 42.23 23.99 27.88 % Of Sales - 22.24% 21.53% 16.78% 14.51% 11.52% 15.04% 13.04% 7.41% 7.51% 6.48% Manufacturing Exp. - 6.28 10.47 19.69 17.88 16.80 22.13 21.49 30.76 26.81 35.44 % Of Sales - 6.06% 7.65% 11.14% 8.19% 6.07% 8.79% 8.22% 5.40% 8.39% 8.24% General & Admin Exp. - 22.75 15.39 29.53 21.15 25.15 30.80 19.75 39.85 35.91 32.50 % Of Sales - 21.96% 11.25% 16.70% 9.69% 9.09% 12.23% 7.56% 6.99% 11.24% 7.56% Selling & Distn. Exp. - 4.23 4.44 7.85 5.31 3.03 4.28 5.28 3.21 3.27 3.61 % Of Sales - 4.08% 3.25% 4.44% 2.43% 1.10% 1.70% 2.02% 0.56% 1.02% 0.84% Miscellaneous Exp. - 0.00 38.00 0.63 0.42 7.75 0.01 5.21 8.23 0.00 3.61 % Of Sales - 0% 27.78% 0.36% 0.19% 2.80% 0.00% 1.99% 1.44% 0% 1.61% EBITDA -3.99 -14.52 -33.13 -187.91 -9.03 32.74 67.49 78.34 250.49 86.83 110.05 EBITDA Margin -4.12% -14.02% -24.22% -106.27% -4.14% 11.84% 26.80% 29.97% 43.96% 27.19% 25.58% Other Income 4.54 4.18 9.57 0.24 1.26 6.53 8.54 1.93 8.75 2.79 1.43 Interest 2.80 2.54 2.41 35.55 39.71 43.44 52.63 53.27 59.02 59.49 66.67 Depreciation 19.64 18.63 18.41 106.91 17.45 16.57 18.26 18.14 26.83 18.79 20.56 PBT -21.89 -31.50 -44.38 -330.13 -64.94 -20.74 5.13 8.85 173.39 11.34 24.25 Tax 0.00 0.00 0.00 -2.12 2.82 -1.57 -1.05 -1.01 47.04 3.21 5.32 Tax Rate 0.00% 0.00% 0.00% 0.64% -4.34% 7.57% -20.47% -11.41% 27.13% 28.31% 21.94% PAT -21.89 -31.50 -44.38 -328.01 -67.75 -19.17 6.19 9.87 126.34 8.13 18.93 PAT before Minority Interest -21.89 -31.50 -44.38 -328.01 -67.75 -19.17 6.19 9.87 126.34 8.13 18.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -22.59% -30.41% -32.44% -185.51% -31.03% -6.93% 2.46% 3.78% 22.17% 2.55% 4.40% PAT Growth 0.00% - - - - - -37.28% -92.19% 1,454.00% -57.05% EPS -2.64 -3.80 -5.35 -39.57 -8.17 -2.31 0.75 1.19 15.24 0.98 2.28

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 108.28 116.27 149.07 187.10 237.29 1,058.80 1,315.17 1,185.66 1,461.91 1,345.63 1,380.10 Net Sales Growth -24.33% -22.00% -20.33% -21.15% -77.59% -19.49% 10.92% -18.90% 8.64% -2.50% Cost Of Goods Sold 52.29 59.85 71.48 271.51 153.49 462.55 518.40 479.67 536.28 624.05 646.23 Gross Profit 55.99 56.42 77.60 -84.41 83.80 596.24 796.77 705.99 925.63 721.58 733.88 GP Margin 51.71% 48.52% 52.06% -45.11% 35.32% 56.31% 60.58% 59.54% 63.32% 53.62% 53.18% Total Expenditure 110.61 129.28 181.95 374.09 245.11 1,052.24 1,146.24 984.93 1,057.46 1,122.68 1,158.21 Power & Fuel Cost - 3.97 5.36 9.12 5.91 42.46 42.77 34.73 34.78 38.26 46.70 % Of Sales - 3.41% 3.60% 4.87% 2.49% 4.01% 3.25% 2.93% 2.38% 2.84% 3.38% Employee Cost - 28.39 34.16 32.67 36.22 233.36 241.76 197.78 189.98 176.94 184.43 % Of Sales - 24.42% 22.92% 17.46% 15.26% 22.04% 18.38% 16.68% 13.00% 13.15% 13.36% Manufacturing Exp. - 8.54 11.11 21.28 22.15 196.36 217.39 176.69 175.06 167.31 179.26 % Of Sales - 7.34% 7.45% 11.37% 9.33% 18.55% 16.53% 14.90% 11.97% 12.43% 12.99% General & Admin Exp. - 22.84 17.27 30.56 21.96 96.13 111.52 78.75 93.93 95.26 76.30 % Of Sales - 19.64% 11.59% 16.33% 9.25% 9.08% 8.48% 6.64% 6.43% 7.08% 5.53% Selling & Distn. Exp. - 5.51 4.58 7.90 5.37 13.82 14.41 16.66 15.39 20.86 25.29 % Of Sales - 4.74% 3.07% 4.22% 2.26% 1.31% 1.10% 1.41% 1.05% 1.55% 1.83% Miscellaneous Exp. - 0.18 38.00 1.05 0.02 7.56 0.00 0.65 12.03 0.00 25.29 % Of Sales - 0.15% 25.49% 0.56% 0.01% 0.71% 0% 0.05% 0.82% 0% 0% EBITDA -2.32 -13.01 -32.88 -186.99 -7.82 6.56 168.93 200.73 404.45 222.95 221.89 EBITDA Margin -2.14% -11.19% -22.06% -99.94% -3.30% 0.62% 12.84% 16.93% 27.67% 16.57% 16.08% Other Income 4.70 4.37 9.98 0.97 1.27 11.95 33.97 23.76 8.09 23.63 8.02 Interest 3.23 2.98 2.98 36.23 39.99 61.03 70.06 82.35 67.79 85.26 86.20 Depreciation 21.23 20.22 19.94 108.41 18.28 66.95 66.79 56.42 58.28 61.39 66.18 PBT -22.09 -31.85 -45.82 -330.65 -64.83 -109.47 66.05 85.71 286.48 99.93 77.54 Tax 0.11 0.11 -0.38 -2.12 2.82 -0.36 8.68 9.62 72.50 16.26 5.49 Tax Rate -0.50% -0.35% 0.83% 0.64% -4.35% 0.33% 13.14% 11.22% 25.31% 16.27% 7.08% PAT -22.20 -31.96 -45.45 -328.54 -67.65 -109.11 57.37 77.94 213.97 83.67 72.05 PAT before Minority Interest -22.20 -31.96 -45.45 -328.54 -67.65 -109.11 57.37 76.09 213.97 83.67 72.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.85 0.00 0.00 0.00 PAT Margin -20.50% -27.49% -30.49% -175.60% -28.51% -10.31% 4.36% 6.57% 14.64% 6.22% 5.22% PAT Growth 0.00% - - - - - -26.39% -63.57% 155.73% 16.13% EPS -2.68 -3.86 -5.48 -39.63 -8.16 -13.16 6.92 9.40 25.81 10.09 8.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 58.49 89.41 133.31 457.27 553.89 572.62 567.41 560.86 369.64 373.95 Share Capital 16.58 16.58 16.58 16.58 16.58 16.50 16.50 16.20 16.20 16.20 Total Reserves 41.91 72.83 116.73 440.69 537.31 556.12 550.90 544.66 353.44 357.75 Non-Current Liabilities 187.25 200.89 250.02 248.69 211.92 243.41 288.29 296.51 549.99 465.19 Secured Loans 0.00 0.00 0.00 0.00 12.29 34.39 66.66 131.24 143.28 260.86 Unsecured Loans 63.32 63.32 61.98 60.61 55.32 55.32 49.30 57.07 49.75 46.94 Long Term Provisions 4.35 4.07 3.95 8.04 3.84 9.54 7.17 2.74 3.38 3.01 Current Liabilities 393.22 391.56 412.65 365.98 301.51 338.52 399.72 503.14 445.75 463.61 Trade Payables 33.65 38.84 56.39 37.41 30.82 35.28 23.39 45.32 24.45 45.61 Other Current Liabilities 122.80 115.07 113.37 93.40 62.54 54.01 76.77 92.03 114.08 101.66 Short Term Borrowings 217.35 218.00 223.37 216.14 187.74 214.13 258.70 305.71 291.91 291.19 Short Term Provisions 19.42 19.65 19.51 19.03 20.41 35.10 40.86 60.07 15.31 25.15 Total Liabilities 638.96 681.86 795.98 1,071.94 1,067.32 1,154.55 1,255.42 1,360.51 1,365.38 1,302.75 Net Block 315.28 326.32 342.86 428.81 356.42 380.70 404.83 432.93 386.94 376.55 Gross Block 514.50 506.90 505.03 565.73 460.09 474.78 480.65 503.31 495.61 466.20 Accumulated Depreciation 199.22 180.58 162.17 136.92 103.67 94.08 75.82 70.39 108.67 89.65 Non Current Assets 391.18 405.75 524.66 629.97 513.68 532.41 599.47 579.17 657.81 669.87 Capital Work in Progress 17.11 20.65 20.66 40.03 69.77 64.18 42.78 58.64 40.83 63.27 Non Current Investment 58.78 58.78 161.13 161.14 87.50 87.53 151.87 87.60 230.05 230.05 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 247.79 276.11 271.32 441.97 553.63 622.14 655.94 781.34 707.57 632.89 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 56.50 62.77 78.31 239.07 263.37 282.45 292.54 285.66 268.17 222.50 Sundry Debtors 45.80 59.54 50.30 63.39 89.67 101.89 167.67 224.85 230.86 228.07 Cash & Bank 0.29 1.14 3.35 6.78 11.09 24.96 9.18 15.55 7.18 13.99 Other Current Assets 145.19 76.88 67.29 15.28 189.51 212.86 186.55 255.26 201.37 168.32 Short Term Loans & Adv. 85.02 75.78 72.07 117.46 168.91 192.30 166.27 238.34 175.74 162.39 Net Current Assets -145.43 -115.45 -141.33 75.99 252.13 283.62 256.22 278.20 261.82 169.27 Total Assets 638.97 681.86 795.98 1,071.94 1,067.31 1,154.55 1,255.41 1,360.51 1,365.38 1,302.76

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds -35.17 -5.46 39.42 364.29 834.59 943.79 1,226.40 734.21 585.15 559.24 Share Capital 16.58 16.58 16.58 16.58 341.80 341.73 341.73 16.20 80.15 80.15 Total Reserves -51.75 -22.04 22.84 347.70 492.79 602.07 884.67 718.01 505.00 479.09 Non-Current Liabilities 547.81 545.61 531.54 528.34 590.94 489.65 356.86 503.86 561.11 538.36 Secured Loans 0.30 0.25 0.34 0.38 414.68 369.08 275.90 396.25 206.75 436.44 Unsecured Loans 63.32 63.32 61.98 60.61 55.71 55.72 49.30 57.07 50.52 46.94 Long Term Provisions 4.82 4.90 4.38 8.36 5.14 9.21 7.03 2.19 3.57 3.17 Current Liabilities 408.21 410.71 424.25 373.39 770.36 888.93 790.23 817.39 897.41 800.86 Trade Payables 39.42 44.07 55.23 41.89 226.50 294.42 201.99 178.59 166.74 188.71 Other Current Liabilities 36.52 127.69 124.45 94.78 101.78 227.11 147.64 179.92 285.85 176.38 Short Term Borrowings 312.71 219.12 224.88 217.59 418.51 332.30 385.16 381.47 407.76 389.38 Short Term Provisions 19.55 19.83 19.69 19.13 23.56 35.10 55.43 77.41 37.06 46.39 Total Liabilities 920.85 950.86 995.21 1,266.02 2,195.89 2,322.37 2,385.77 2,055.46 2,043.67 1,898.46 Net Block 407.67 417.93 435.81 519.89 1,045.12 964.92 1,035.36 878.90 814.17 813.47 Gross Block 751.68 742.05 740.00 802.44 1,271.07 1,156.58 1,128.64 915.77 1,663.33 1,599.11 Accumulated Depreciation 344.01 324.12 304.18 282.54 225.95 191.65 93.29 36.87 849.16 785.64 Non Current Assets 593.28 607.89 656.06 758.75 1,220.61 1,091.77 1,103.83 961.04 911.03 906.45 Capital Work in Progress 17.11 20.65 20.66 40.03 89.28 122.31 65.27 76.13 94.17 90.28 Non Current Investment 168.50 168.50 198.82 198.82 85.71 2.51 2.70 2.71 2.69 2.70 Long Term Loans & Adv. 0.00 0.34 0.32 0.00 0.00 1.52 0.00 2.81 0.00 0.00 Other Non Current Assets 0.00 0.48 0.44 0.00 0.50 0.50 0.50 0.50 0.00 0.00 Current Assets 327.56 342.97 339.14 507.27 975.28 1,230.61 1,281.94 1,094.42 1,132.60 991.96 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 58.76 64.06 79.76 240.77 501.91 563.69 540.17 483.97 490.80 431.43 Sundry Debtors 74.11 82.82 74.16 87.36 249.07 356.11 275.43 200.14 326.24 329.58 Cash & Bank 0.71 2.03 3.76 7.18 50.49 95.31 99.03 55.47 30.96 26.67 Other Current Assets 193.99 9.59 15.28 15.87 173.82 215.51 367.32 354.84 284.61 204.28 Short Term Loans & Adv. 132.55 184.47 166.19 156.09 140.96 184.76 337.73 332.31 272.88 185.21 Net Current Assets -80.64 -67.74 -85.10 133.88 204.92 341.68 491.71 277.03 235.19 191.10 Total Assets 920.84 950.86 995.20 1,266.02 2,195.89 2,322.38 2,385.77 2,055.46 2,043.67 1,898.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 5.73 -96.52 32.87 25.31 75.02 82.04 206.55 28.17 -54.21 41.29 PBT -30.92 -44.38 -330.13 -64.38 -20.74 5.13 8.85 173.39 11.34 24.25 Adjustment 21.16 20.31 142.19 56.98 59.57 62.82 69.62 80.21 37.74 50.36 Changes in Working Capital 15.49 -72.46 220.80 32.71 42.23 40.35 144.61 -213.96 -103.30 -33.33 Cash after chg. in Working capital 5.73 -96.52 32.87 25.31 81.05 108.30 223.09 39.64 -54.21 41.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 -6.03 -26.26 -16.54 -11.47 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.06 99.83 -1.60 -11.34 3.32 56.17 -38.12 29.83 -11.15 -50.04 Net Fixed Assets -4.06 -1.86 80.07 -75.90 9.10 -15.53 38.52 -25.51 -6.97 -49.04 Net Investments 0.00 102.35 0.01 -73.64 0.03 64.34 -64.27 142.45 0.00 -2.50 Others 0.00 -0.66 -81.68 138.20 -5.81 7.36 -12.37 -87.11 -4.18 1.50 Cash from Financing Activity -2.53 -5.51 -34.70 -13.21 -91.42 -123.23 -174.80 -49.62 58.54 9.48 Net Cash Inflow / Outflow -0.86 -2.20 -3.43 0.76 -13.07 14.98 -6.38 8.38 -6.82 0.74 Opening Cash & Equivalents 1.14 3.35 6.78 6.02 24.16 9.18 15.55 7.18 13.99 13.26 Closing Cash & Equivalent 0.29 1.14 3.35 6.78 11.09 24.16 9.18 15.56 7.18 13.99

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -1.75 -23.99 35.32 27.54 79.56 422.14 21.42 57.96 154.12 140.48 PBT -31.50 -45.82 -330.65 -64.28 -109.47 66.05 85.71 286.48 99.93 77.54 Adjustment 23.17 22.37 144.31 58.04 125.89 134.05 135.90 124.15 101.94 111.32 Changes in Working Capital 6.64 -0.64 221.66 33.77 83.08 237.03 -158.14 -315.94 -47.75 -48.38 Cash after chg. in Working capital -1.69 -24.09 35.32 27.54 99.50 437.13 63.48 94.69 154.12 140.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.09 0.09 0.00 0.00 -19.94 -14.99 -42.06 -36.73 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -0.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.53 28.29 -4.97 -16.41 -196.01 -88.87 -163.53 -68.49 -190.42 -106.71 Net Fixed Assets -4.06 -1.86 80.07 -75.90 9.10 -15.53 38.52 -25.51 -6.97 -49.04 Net Investments 0.00 102.35 0.01 -73.64 0.03 64.34 -64.27 142.45 0.00 -2.50 Others -0.47 -72.20 -85.05 133.13 -205.14 -137.68 -137.78 -185.43 -183.45 -55.17 Cash from Financing Activity 4.96 -6.03 -33.78 -10.38 72.44 -337.80 185.66 35.05 40.59 -41.67 Net Cash Inflow / Outflow -1.32 -1.74 -3.42 0.75 -44.02 -4.53 43.56 24.51 4.29 -7.90 Opening Cash & Equivalents 2.03 3.76 7.18 6.43 94.50 99.03 55.47 30.96 26.67 34.57 Closing Cash & Equivalent 0.71 2.03 3.76 7.18 50.49 94.50 99.03 55.47 30.96 26.67

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 2.47 6.20 11.50 50.57 62.22 64.78 64.15 64.53 45.50 46.03 ROA -4.77% -6.01% -35.12% -6.25% -1.73% 0.51% 0.75% 9.27% 0.61% 1.51% ROE -87.61% -60.50% -127.49% -14.96% -3.65% 1.16% 1.88% 28.34% 2.19% 5.09% ROCE -7.04% -9.34% -47.20% -3.18% 2.67% 6.22% 6.01% 22.55% 6.95% 8.74% Fixed Asset Turnover 0.20 0.27 0.33 0.40 0.59 0.53 0.53 1.14 0.66 0.92 Receivable days 185.55 146.54 117.34 117.08 126.38 195.36 274.06 145.95 262.23 174.74 Inventory Days 210.09 188.21 327.56 411.82 360.12 416.73 403.70 177.37 280.37 166.58 Payable days 226.76 258.17 63.72 89.46 51.74 43.93 69.44 41.99 56.35 44.37 Cash Conversion Cycle 168.88 76.58 381.18 439.44 434.76 568.16 608.32 281.33 486.25 296.96 Total Debt/Equity 18.29 7.30 3.95 0.85 0.59 0.65 0.84 1.09 1.62 1.87 Interest Cover -11.41 -17.39 -8.29 -0.64 0.52 1.10 1.17 3.94 1.19 1.36

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) -8.82 -5.24 0.17 39.35 56.85 70.35 104.60 85.93 64.20 61.00 ROA -3.42% -4.67% -29.06% -5.29% -4.83% 2.44% 3.43% 10.44% 4.25% 3.86% ROE 0.00% 0.00% -200.51% -18.80% -20.75% 7.95% 9.76% 35.18% 16.50% 14.90% ROCE -9.07% -12.01% -55.28% -3.54% -2.69% 7.03% 9.04% 21.86% 11.93% 10.91% Fixed Asset Turnover 0.16 0.20 0.24 0.30 0.87 1.15 1.16 1.13 0.82 0.88 Receivable days 246.32 192.18 157.55 149.87 104.31 87.64 73.20 65.71 88.94 89.58 Inventory Days 192.78 176.07 312.65 381.82 183.67 153.18 157.64 121.69 125.08 113.47 Payable days 254.58 253.55 65.28 90.54 92.05 79.66 70.90 60.76 60.42 57.00 Cash Conversion Cycle 184.52 114.70 404.91 441.16 195.94 161.15 159.93 126.64 153.61 146.05 Total Debt/Equity -5.14 -8.67 266.22 1.10 1.18 1.05 0.69 1.45 1.63 1.81 Interest Cover -9.69 -14.36 -8.13 -0.62 -0.79 1.94 2.04 5.23 2.17 1.90

Top Investors:

kitara piin 1102

krone finstock pvt ltd

william f harvey

sameer mahendra sampat

k india opportunities fund limited pcc - cell s

ashish bharatkumar shah

monarch networth finserve private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Vivimed Labs - Quarterly Results
13th Aug 2025, 22:34 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback